U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H14ClNOS
Molecular Weight 291.796
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of T-62

SMILES

NC1=C(C(=O)C2=CC=C(Cl)C=C2)C3=C(CCCC3)S1

InChI

InChIKey=OTZVBZFYMFTYKH-UHFFFAOYSA-N
InChI=1S/C15H14ClNOS/c16-10-7-5-9(6-8-10)14(18)13-11-3-1-2-4-12(11)19-15(13)17/h5-8H,1-4,17H2

HIDE SMILES / InChI

Molecular Formula C15H14ClNOS
Molecular Weight 291.796
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/20547736 | https://www.ncbi.nlm.nih.gov/pubmed/22148748 | https://www.google.ch/patents/US20020055535

T-62 ((2-amino-4,5,6,7-tetrahydro-1-benzothien-3-yl)(4-chlorophenyl)methanone) is a small-molecule allosteric potentiator of agonist function at the adenosine A1 receptor, developed by Edward Leung for the treatment of various pain states in a mammal and human subjects.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancer.
2006-03-01
Patents

Patents

Sample Use Guides

When given orally, a dose range of 100 mg to 1000 mg (approximately 1 to 15 mg/kg free base per dose) can be given to a patient.
Route of Administration: Oral
FlpIn Chinese hamster ovary (CHO) cells stably expressing adenosine A1 receptors were used for activity evaluation. Membrane homogenates (15 mkg) were equilibrated with [3H]CCPA (2 nM) in a 1-ml total volume of assay buffer for 90 min at 30°C. R-PIA (10 mkM), alone or in the presence of T62, VCP520, or VCP333, was then added at various time points to prevent the reassociation of [3H]CCPA with the receptor. In subsequent experiments designed to investigate the effect of a range of modulator concentrations on [3H]CCPA dissociation rate, a “two-point kinetic” experimental paradigm was used in which the effect of increasing concentrations of allosteric ligand on [3H]CCPA dissociation was determined at 20 and 90 min.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:08:03 GMT 2025
Edited
by admin
on Mon Mar 31 18:08:03 GMT 2025
Record UNII
9Q765ZIF8L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
T-62
Preferred Name English
Code System Code Type Description
EPA CompTox
DTXSID20193322
Created by admin on Mon Mar 31 18:08:04 GMT 2025 , Edited by admin on Mon Mar 31 18:08:04 GMT 2025
PRIMARY
CAS
40312-34-3
Created by admin on Mon Mar 31 18:08:04 GMT 2025 , Edited by admin on Mon Mar 31 18:08:04 GMT 2025
PRIMARY
PUBCHEM
855908
Created by admin on Mon Mar 31 18:08:04 GMT 2025 , Edited by admin on Mon Mar 31 18:08:04 GMT 2025
PRIMARY
DRUG BANK
DB12919
Created by admin on Mon Mar 31 18:08:04 GMT 2025 , Edited by admin on Mon Mar 31 18:08:04 GMT 2025
PRIMARY
FDA UNII
9Q765ZIF8L
Created by admin on Mon Mar 31 18:08:04 GMT 2025 , Edited by admin on Mon Mar 31 18:08:04 GMT 2025
PRIMARY